Compare Liquidia Corporation Common Stock (LQDA) vs NeoGenomics Inc. Common Stock (NEO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Liquidia Corporation Common Stock vs NeoGenomics Inc. Common Stock — how do they compare? Liquidia Corporation Common Stock trades at $33.81 (market cap $3.04B), while NeoGenomics Inc. Common Stock trades at $17 (market cap $2.17B). The key difference: Liquidia Corporation Common Stock is the larger of the two by market cap, and NeoGenomics Inc. Common Stock is trading nearer its 52-week high, Liquidia Corporation Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Liquidia Corporation Common Stock for 0 Days and NeoGenomics Inc. Common Stock for 0 Days on average.
| LQDA | NEO | |
|---|---|---|
Market Cap | $3.04B | $2.17B |
Volume | 21,111,778 | 1,615,943 |
Sector | Health | Health |
52-Week High | $91.03 | $19.91 |
52-Week Low | $22.02 | $7.19 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $2.94B | $2.47B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Liquidia Corporation Common Stock
Liquidia Corporation is a biopharmaceutical company that develops therapies for rare cardiopulmonary diseases, including YUTREPIA, an inhaled treprostinil powder for pulmonary hypertension built on its PRINT technology.
Read more on LQDA →About NeoGenomics Inc. Common Stock
NeoGenomics, Inc. is a US cancer diagnostics company that provides genomic and pathology testing services, offering an oncology-focused testing menu used by oncologists, pathologists, and hospital systems across the cancer care continuum.
Read more on NEO →
